SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Resmed (RMD)
RMD 252.33-0.5%Oct 30 3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Angelo Ferraro who wrote (1)11/24/1999 4:45:00 AM
From: Henrik  Read Replies (1) of 8
 
ResMed Inc. Added to S&P SmallCap 600 Index
Angelo,
S&P SmallCap inclusion and ASX listing should have positive long term impact on the stock.
Regards, Henrik
---------------------------------------------------------
biz.yahoo.com

Tuesday November 23, 5:48 pm Eastern Time
Company Press Release
SOURCE: Standard & Poor's
ResMed Inc. Added to S&P SmallCap 600 Index

NEW YORK, Nov. 23 /PRNewswire/ -- Standard & Poor's will replace Merrill Corp. (Nasdaq: MRLL - news) in the
S&P SmallCap 600 Index with ResMed Inc. (NYSE: RMD - news) after the close of trading on Wednesday, November 24, 1999. DLJ Merchant Banking Partners II (an investment company) is acquiring Merrill Corp. through a recapitalization of the company.
ResMed Inc. designs, manufactures and distributes medical equipment for treating and diagnosing sleep disordered breathing, primarily obstructive sleep apnea. The company, headquartered in San Diego, California, will be added to the S&P SmallCap 600 Health Care (Medical Products & Supplies) industry group.

(truncated - hit on the link to get full press release)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext